Physician profile
Mark D Lebeda
NPI 1679537278
$2,672.76
in general payments reported to CMS, 2019-2025
27 companies · $753 in 2025
The $753 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $162 · 2021: $139 · 2022: $345 · 2023: $329 · 2024: $618 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $589.24 | 2019-2023 | Trudi Nav Cable, Acclarent Aera |
| Integra Lifesciences Corporation | $362.60 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Genzyme Corporation | $314.66 | 2019-2025 | |
| Glaxosmithkline, LLC. | $306.15 | 2022-2025 | Nucala |
| Stryker Corporation | $207.10 | 2019-2025 | Medline Industries, INC. |
| Optinose US, INC. | $133.15 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $117.33 | 2024-2025 | Dupixent |
| Neurent Medical Limited | $116.95 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Aerin Medical INC. | $48.24 | 2022-2023 | |
| Shire North American Group INC | $45.72 | 2019 | |
| Kerecis Limited | $45.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ars Pharmaceuticals Operations, INC. | $43.19 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $41.66 | 2019 | |
| Inspire Medical Systems, INC. | $41.00 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $32.82 | 2025 | Keytruda |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortovia Therapeutics, INC. | $29.05 | 2019 | |
| Convatec INC. | $24.13 | 2025 | |
| Intersect Ent, INC. | $22.12 | 2019 | |
| Phadia US INC. | $19.66 | 2023 | Immunocap |
| Pfizer INC. | $19.56 | 2023 | |
| Olympus America INC. | $18.54 | 2019 | |
| Cochlear Americas | $18.43 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Medtronic, INC. | $17.53 | 2022 | |
| Xoran Technologies LLC | $15.71 | 2021 | |
| Alk-Abello, INC | $14.79 | 2022 | |
| Karl Storz Endoscopy-America | $14.46 | 2023 | Image 1 |
| Arbor Pharmaceuticals, INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lebeda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.